25 October 2024 : Clinical Research
Type 2 Diabetes Subtypes and Their Role in Metabolic Liver Disease and Fibrosis Progression
Froylan David Martínez-Sánchez
12ABCDEF, David Medina-Julio 12BCEF, Jacqueline Córdova-Gallardo 13ADE, Maria Juliana Corredor Nassar 2BDE, Nahum Méndez-Sánchez 14ADE*
DOI: 10.12659/MSM.946016
Med Sci Monit 2024; 30:e946016
Figure 2 Association of type 2 diabetes subgroups with advanced liver fibrosisLogistic regression analysis adjusted by hypertension, metformin, subcutaneous insulin, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase 4 inhibitors, glucagon-like peptide-1 agonists, pioglitazone, sulfonylureas, fibrates, statins, serum creatinine, and microalbuminuria. Mild obesity-related diabetes was considered as the reference group. Dashed lines represent the univariate model, and solid lines represent the multivariate model.